Meritage Portfolio Management Dexcom Inc Transaction History

Meritage Portfolio Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$78.0 - $104.5 $1.12 Million - $1.49 Million	-14,301 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$95.51 - $112.95 $4,488 - $5,308	-47 Reduced 0.33%	14,301 $5.9 Million
Q2 2020 Jul 27, 2020	BUY	$62.68 - $105.34 $899,332 - $1.51 Million	14,348 New	14,348 $5.82 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

Stay updated on Meritage Portfolio Management with notifications on news.